chrisvoncsefalvay/vaers-outcomes huggingface dataset:
15 y/o male with hx of faint/pale from previous other vaccines (came back to normal within first 10 minutes) came to our pharmacy to get his 1st Pfizer COVID-19 vaccine. His mother and the patient both aware of the vaccine may cause the similar reaction and agreed to get the vaccine.  Around 4:10pm I gave him a candy, then I have administered the vaccine. I monitored him about 2 minutes, I asked if he wanted some water, he said yes. While I went to go grab a bottle of water, he fainted and fell on ground.   He started turning pale, showing of cold sweat, and twitching. I continuously monitored, checked his vital which was within normal range. He was responsive to my questions. 5 minutes later, he wanted to throw up and his mother told us he ate around 2pm.  Around 4:40pm I had someone to call 911 for medical checkup after patient's mom agreed to.  EMS arrived within 10 minutes, they checked vital and his condition. After the examination, they concluded that he had a shock from the fear of the needle.   My concern is that he was able to answer with shaking & nodding his head, and thumbs up and down, however not able to speak.  Medics tried to make him to say his name, but he was not able to. Patient's mother decided to carry him to the ambulance. I will make a follow up call to the patient to see if any progress is made.
Client phoned health unit to report that she broke out with blisters from the tip of nose to the bridge of her nose after receiving the shingles vaccine. Approx. 10 blisters, some were fluid filled, red, with some itching x 3 weeks. Last spoke to patient still had some blisters.
Chills, aches, minor headache, minor nausea, and fatigue; Chills, aches, minor headache, minor nausea, and fatigue; Chills, aches, minor headache, minor nausea, and fatigue; Chills, aches, minor headache, minor nausea, and fatigue; Chills, aches, minor headache, minor nausea, and fatigue; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sales Representative. A 63-years-old patient of an unspecified gender received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, Lot # EL8982, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took warfarin for cerebrovascular accident, anastrazol vegal for neoplasm malignant. On an unspecified date the patient experienced chills, aches, minor headache, minor nausea, and fatigue. At the time of the report the event outcome was unknown.  No follow-up attempts are possible. No further information is expected.
2 days post injection developed a red rash that spread from (L) shoulder to (L) elbow. Pruritic and painful. There was no reported systemic symptoms.
Menactra vaccine administration was at 9 y of age for a patient with no reported adverse event; Initial information received on 18-Jun-2023 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 9 years old and unknown gender patient who had meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] administration was at 9 y of age for a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect meningococcal A-C-Y-W135 (D CONJ) vaccine Solution for injection lot number not reported via unknown route in unknown administration site (dose, frequency, strength and expiration date: not provided) for immunization and menactra vaccine administration was at 9 y of age for a patient with no reported adverse event (inappropriate schedule of product administration) (unknown latency) following the administration of meningococcal a-c-y-w135 (d conj) vaccine. Information on the batch number was requested.  It was reported Menactra vaccine administration was at 9 y of age for a patient. What should be done done next with this patient vaccine schedule  Action taken- not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Received 2nd Moderna shot 2/24/21. 1day later developed ?severe? sinus drainage and continual sneezing, and loss of taste.  Is this just coincidental?  Remain isolated from others due to age- so it?s hard to believe it?s a cold bc of lack of exposure to others.
After receiving annual flu shot for the hospital I work for, I felt pain immediately and realized that a nursing student in training had given it to me very high on my arm, really at the shoulder location.  I immediately felt distinct pain down from my shoulder to my elbow. I knew this was not the right location since I have been getting flu hots all of my adult life.  I continued to feel pain and weakness when trying to raise my left arm for weeks after. Finally went to employee health Dept in hospital where they filed for workers compensation and scheduled appt with orthopedic doctor. He gave a cortisone shot and I finally feel relief.
13 year old previously healthy male presenting on 6/13/2021 with petechiae and ecchymosis. Found to have thrombocytopenia (platelet count 2). Diagnosed with ITP. Currently admitted and receiving IVIG. No adverse sequelae of ITP thus far.
Bad headache; This is a spontaneous report received from Other Company. A contactable 70-year-old female reported for herself. A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot/batch number and Expiration were not reported) via an unspecified route of administration on an unspecified date as 2nd dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 for COVID-19 immunisation. On an unspecified date, the patient had experienced a bad headache after the 2nd COVID-19 vaccine and about 24 hours. The clinical outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Attempted to give Vaccine via ID route on Left arm.  Weal was developing and vaccine started to leak out.  Removed needle upon leak.  Revaccinated on Right arm with new dose/needle/syringe.  Rationale for revaccinating explained. Client reported that he also had a flu vaccine on 09/23/2022. Was not recorded in the Immunization Registry.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 72-year-old male patient received BNT162b2 (BNT162B2), on 22Dec2020 at 07:00 as dose 1, single (Lot number: EL0142), in left arm, on 13Jan2021 at 07:30 as dose 2, single (Lot number: EL1283), in right arm and on 04Oct2021 at 12:00 as dose 3 (booster), single (Lot number: FF2569) at the age of 71 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 02May2022 at 12:00 as dose 4 (booster), single (Lot number: 049L21A), in left arm for covid-19 immunisation. The patient had no relevant medical history. No known allergies. Concomitant medication(s) included: TYLENOL, start date: 27Sep2022, stop date: 03Oct2022; NEURONTIN, start date: 22Sep2022, stop date: 25Sep2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Sep2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Sep2022) Positive, notes: Indication: Covid-19 treatment. Therapeutic measures were taken as a result of treatment failure, covid-19 included: COVID-19 Treatment (Brand: Pfizer, Lot number: GF1696) from 27Sep2022 to 01Oct2022 for treatment of COVID-19.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect products to the reported event vaccination failure and Covid-19  cannot be completely excluded.
Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. On 02-JUN-2016 the patient was vaccinated with an improperly stored dose of (wistar ra 27-3) M-M-R-II 0.5 ml (rHA (recombinant human albumin), lot #J014876, expiration date 16-JUL-2017, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the second time was 3156 hours with the lowest recorded temperature of 20 Fahrenheit degree. The total cumulative excursion time of the second time was 9120 hours with the lowest recorded temperature of 27 Fahrenheit degree. The storage criteria of this vaccine was refrigerator/freezer (R/F) and the type of excursion was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
When I woke up on Sunday morning, i was unable to put weight on my right foot.  Had to use a chain.  Felt better that evening.   Monday morning at 430 am woke up and could not get.up due to dizziness and nausea.  Transported to hospital er.  After examination and blood work was given meclizine and odestranon.   Later nurse came in and said my potassium was so low that I had to have an IV and 2 large potassium tablets.   Definitely a shock because blood work taken on Jan 21 showed potassium was fine.  Never had a problem with low potassium in my life.   My question to the emergency room physician how could this happen in a little over 3 weeks.  He could not explain.  A MRI was ordered and everything was ok.  Sent home with medication.  On Tuesday went to my Pcp office and was seen by another doctor in the practice because my doctor was out of the office.  Still very dizzy.   Blood pressure was up to 182.  Again this is unusual.   With my medication my pressure is usually 132 over 70 or 80.  Blood work was taken.  Later that evening it was reported that my iron was very low.   Again never had this problem before.  Left office with prednisone and now taking iron tablets.  Forgot to say that when I left emergency room I was give potassium pills to take for three days. I am still dizzy and suffering from nausea. Prior to the shot, I was fine.  No problems and no one can explain to me why I am still feeling horrible to include low energy level.  Was told that I might have Vertigo.  I informed the doctor that prior to July 2015 I did suffer with vertigo but not now
I had arm swelling, hives, area was hot to touch, muscle tightness in face neck and chest. Had nausea/dizziness and extreme fatigue  for 5 days. Felt like heart was racing a couple times with pain in rib cage area. Also had gotten a few sores in my mouth. Was told to take Bendadryl and did that for a couple days along with Ibuprofen and tramadol for pain.
The patient experienced no symptoms; a patient was administered an improperly stored dose of VARIVAX; Route of Administration: "intramuscular"; This spontaneous report was received from an administrator (also reported as healthcare business professional) referring to a patient of unknown age and gender. Concomitant therapies included sterile diluent.  Information about pertinent medical history, drug reactions or allergies was not provided.      On 06-DEC-2019, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # S012036, expiration date 17-APR-2021, dosage detail and strength was not provided) intramuscularly for prophylaxis (product storage error, incorrect route of product administration). Administered doses of vaccine experienced temperature excursion of -10.6 degrees Celsius (C) for 24 minutes. There was no previous temperature excursion. Digital data logger was involved. The patient experienced no symptoms.
I started having severe nerve pain in back of left shoulder that would radiate down my arm. This was causing me to lose sleep lasting few weeks.I thought it was my Rheumatoid went to see my Rheumatologist doctor had blood work. After I received Dose 2 and Dose 3 the symptoms increased. I have seen the Chiropractor for the nerve pain and Rheumatologist still present today.
PATIENT WAS WELL ON 01/30/22, WENT TO BED AND DIED IN HER SLEEP
First asthma attack in 15 years. Needed to be prescribed medication to control attack. Starting 3 days after the vaccine, and continuing to this day, I have a chronically dry throat or some inflammation in my throat area causing me to choke often, and my voice is chronically hoarse.
Reported dizziness and lightheadedness 4 minutes after injection. VSS. Laid on stretcher for 30 minutes and felt good enough to go home.
had incorrectly been given injections of expired Moderna vaccine; general malaise; headaches for several days; injection site soreness; injection site soreness and swelling; administered vaccine that was "not stored properly"/"room temperature since Monday"/in syringes that were kept in non-sterile conditions without temperature or other controls; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (administered vaccine that was "not stored properly"/"room temperature since Monday"/in syringes that were kept in non-sterile conditions without temperature or other controls), EXPIRED PRODUCT ADMINISTERED (had incorrectly been given injections of expired Moderna vaccine), MALAISE (general malaise), HEADACHE (headaches for several days) and VACCINATION SITE PAIN (injection site soreness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided.  Concomitant products included CELECOXIB (CELEBREX) from 01-Jan-2010 to an unknown date for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (administered vaccine that was "not stored properly"/"room temperature since Monday"/in syringes that were kept in non-sterile conditions without temperature or other controls). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (had incorrectly been given injections of expired Moderna vaccine), MALAISE (general malaise), HEADACHE (headaches for several days), VACCINATION SITE PAIN (injection site soreness) and VACCINATION SITE SWELLING (injection site soreness and swelling). On 29-Apr-2021, PRODUCT STORAGE ERROR (administered vaccine that was "not stored properly"/"room temperature since Monday"/in syringes that were kept in non-sterile conditions without temperature or other controls) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (had incorrectly been given injections of expired Moderna vaccine), MALAISE (general malaise), HEADACHE (headaches for several days), VACCINATION SITE PAIN (injection site soreness) and VACCINATION SITE SWELLING (injection site soreness and swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported patient was getting Johnson and Johnson vaccine The Owner at the vaccination facility called and stated the vaccine that was given was supposed to be destroyed on Monday (26-Apr-2021), and that it was "not stored properly", "room temperature since Monday".   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow up information received on 1-jun-2021, patient demographic details updated, new events and  dose information of concomitant medication updated.
Neck is a little bit swollen; Colds; Bruised/ Has a bruise in right arm; Had a 102.6 temperature / high fever; Aches and Pains; Arm real sore; Headache; Very tired; Vomiting; This is a spontaneous report from a contactable consumer (patient herself). A 60-years-old non-pregnant female patient received bnt162b2 (BNT162B2, formulation: solution for injection, Lot Number: EL9267) via an unspecified route of administration in Arm Right on 10Feb2021 15:45 as dose 1, single (at the age of 60 years) for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Medical history included penicillin allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 11Feb2021 at 09:00, the patient experienced bruised/has a bruise in right arm, had a 102.6 temperature/high fever, vomiting, aches and pains, arm real sore, headache, very tired. On an unspecified date in Apr2021, the patient experienced neck is a little bit swollen, colds. The patient underwent lab tests and procedures which included body temperature: 102.6 on 11Feb2021 102.6 temperature. Patient took Tylenol and rested as therapeutic measures for bruised/has a bruise in right arm, had a 102.6 temperature/high fever, vomiting, aches and pains, arm real sore, headache, very tired. The outcome of the events bruised/has a bruise in right arm, had a 102.6 temperature/high fever, vomiting, aches and pains, arm real sore, headache, very tired was recovered with Sequel and other events was unknown.   No follow-up attempts are needed. No further information is expected.
fever, head ache, joint pain, tiredness, no appetite, blisters( like pimples) on the chest and both thighs
The mom stated that the child had a slight temp the 2nd night after shots. Her body started jerking which lasted several minutes. Mom did not try to arouse child. Child resumed normal sleep after a total of 3 episodes. Mom never notified the MD of events.
Sore arm; This is a spontaneous report from a contactable consumer via a Pfizer sales representative. A male patient of an unspecified age (reported as Age: 66, unit: unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm after use of product on an unspecified date. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
It was reported the patient was tired the next day and lethargic after the 1st dose, 2nd dose and 1st booster.; It was reported the patient was tired the next day and lethargic after the 1st dose, 2nd dose and 1st booster.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.   A 54-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LETHARGY (non-serious), FATIGUE (non-serious) all with onset 2021, latency 1 day after the suspect product(s) administration, outcome "unknown" and all described as "It was reported the patient was tired the next day and lethargic after the 1st dose, 2nd dose and 1st booster.".  Additional Information: On 28Nov2022, it was reported that a patient started treatment on an unspecified date in early 2021 with Pfizer Covid-19 Vaccine dose 1, on an unspecified date (reported as 2 months later) with Pfizer Covid-19 Vaccine dose 2, on an unspecified date in Sep2021 with Pfizer Covid-19 Vaccine dose 3 (reported as 1st booster) and on an unspecified date in Apr2022 with dose 4 (reported as 2nd booster) for Covid-19 immunization. It was reported the patient was tired the next day and lethargic after the first dose, second dose and first booster. No further follow-up was anticipated.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201375580 same patient different dose number/ event;US-PFIZER INC-202201375581 same patient /event different dose number;US-PFIZER INC-202201375582 same patient different dose number/ event;
This spontaneous report was received from a consumer refers to her son as a male patient of unknown age. On 07-APR-2015, the patient was vaccinated with MMR II INJ initial dose (dose and lot# were not reported). On 18-APR-2015, the patient experienced mild fever, rash and scrotal swelling. It was not specified if the patient will receive the subsequent doses. On an unknown date, the patient sought medical attention by an office visit. Action taken was not applicable. The outcome of reported events was unknown. Causality was not assessed by the reporter. Additional information has been requested.
light fever under 100degF; tired; lethargic; positive for Covid two days later; sore arm from the vaccine; body ache for week and half; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (positive for Covid two days later), MYALGIA (body ache for week and half), PYREXIA (light fever under 100degF), FATIGUE (tired) and LETHARGY (lethargic) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included LOSARTAN for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced MYALGIA (body ache for week and half). On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm from the vaccine). On 31-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (positive for Covid two days later). On an unknown date, the patient experienced PYREXIA (light fever under 100degF), FATIGUE (tired) and LETHARGY (lethargic). The patient was treated with PARACETAMOL (TYLENOL) for COVID-19, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for COVID-19, at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (positive for Covid two days later), MYALGIA (body ache for week and half), PYREXIA (light fever under 100degF), FATIGUE (tired), LETHARGY (lethargic) and PAIN IN EXTREMITY (sore arm from the vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, SARS-CoV-2 test positive: positive positive (Positive) Positive for Covid two days later.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.